Menu

Telehealth guide · 3 min read

An online GLP-1 review checks your history, medicines and risks.

The short answer

A licensed clinician reviews your health history, current medicines, weight history and goals. They look for reasons a GLP-1 may not fit, such as certain thyroid cancers, pancreatitis, pregnancy plans or upcoming surgery. They may ask for labs or records. The clinician, not the website, decides whether treatment is appropriate, and the answer can be no.

Livozo expects to offer clinician-reviewed access to semaglutide and tirzepatide through a licensed clinical partner. Care is not live today. This guide does not recommend a specific medication.

What a clinician reviews

A useful intake covers your weight history, health conditions, current medicines, allergies and goals. It should ask about a personal or family history of medullary thyroid carcinoma or MEN 2, because the branded GLP-1 labels list these as reasons not to use the drug.[1][2]

The labels also point to other topics a clinician should raise. These include past pancreatitis, gallbladder disease, severe gastroparesis, kidney problems, diabetic eye disease, pregnancy or plans to become pregnant, and any planned surgery.[1][2]

Your other medicines matter too. Insulin and some diabetes pills can raise the risk of low blood sugar with a GLP-1. Tirzepatide can make oral birth control pills less reliable for a period after starting and after each dose increase.[1][2]

Who decides

A licensed partner clinician decides whether a GLP-1 is appropriate. Livozo does not prescribe, diagnose or dispense. The clinician may ask for recent labs, medical records or a video visit before deciding.

A careful review can end in a no. It can also end in a different plan, such as more testing first. That is a sign the review is real, not a failure of the service.

Some services market lower or “micro” GLP-1 doses. Microdosing is not an FDA-approved dosing regimen, and the evidence for it is limited. Ask the clinician to explain why a dose is chosen.

Warning signs of a weak review

Be cautious if a service promises approval, asks no questions about your history or never names the dispensing pharmacy. Be cautious too if there is no clear way to reach a clinician after the first decision.

FDA advises buying prescription medicine only from pharmacies that require a valid prescription and hold a state license. Its BeSafeRx program lists warning signs of unsafe online sellers.[3]

Questions to ask before you begin

Who is the clinician, and in which state are they licensed? Which pharmacy will fill the prescription, and is the medicine branded or compounded?[4]

How often will we check in, and what happens if side effects get worse? Who do I contact at night or on weekends if I feel unwell?

What we know

  • Branded GLP-1 labels list clear reasons not to use the drug, such as medullary thyroid carcinoma or MEN 2.
  • Other medicines, including insulin and oral birth control, can change the risks or the plan.
  • FDA advises using licensed clinicians and state-licensed pharmacies.

What we don't know yet

  • How thorough any given online service's review is. Quality varies widely.
  • Whether lower “micro” doses help, because evidence is limited and the regimen is not FDA-approved.
  • How well short online intakes catch every risk compared with in-person care.

Safety

  • Answer every intake question fully and truthfully. Missing details can hide real risks.
  • Tell the clinician about every medicine and supplement you take.
  • Seek urgent care for severe stomach pain, signs of a serious allergic reaction or fainting.

This guide is education, not medical advice. It does not create a clinician-patient relationship. If you think you are having an emergency, call 911.

Sources

  1. DailyMed (NLM) — Wegovy (semaglutide) prescribing information
  2. DailyMed (NLM) — Zepbound (tirzepatide) prescribing information
  3. FDA — BeSafeRx: your source for online pharmacy information
  4. FDA — FDA's concerns with unapproved GLP-1 drugs used for weight loss

Keep reading.